PARLIAMENTARY DEBATE
Coronavirus Response - 20 July 2020 (Commons/Commons Chamber)
Debate Detail
Thanks to the perseverance of the British people and the hard work of those on the frontline, this virus is on the back foot. For over three weeks now, the number of new cases each day has been below 1,000, and daily hospital admissions are down to 142. Because of this success in slowing the spread of the virus, on Friday, the Prime Minister was able to set out a conditional timetable for the further easings of the restrictions.
Throughout the reopening, we have acted carefully and cautiously, always vigilant, and we have been able to deliver on our plan. We have protected the NHS. We have cautiously replaced the national lockdown with local action. Thanks to our action against hundreds of local outbreaks, and thanks to NHS Test and Trace working well, NHS Test and Trace has now asked 180,000 people to self-isolate—that is up to 180,000 potential chains of transmission broken by this brilliant new service. What is more, in the hundreds of thousands of tests it delivers every single day, the vast—vast—majority test negative. That provides assurance to hundreds of thousands of people who can go back to work and sleep easy.
NHS Test and Trace is a brand new service. Putting together a massive service of this kind, at this pace, has been a remarkable job—almost unprecedented. I would like to thank the remarkable leadership of Baroness Harding for spearheading the programme and Tom Riordan, who has driven our vital work with local authorities. Everybody in this country who loves freedom should join me in thanking all those who work in NHS Test and Trace, in Public Health England, and in local public health operations for successfully delivering on our plan of moving from a national lockdown to local action. The plan is working.
I would like, if I may, to set out the next stages in this plan. We refuse to be complacent about the threat posed by the virus, and we will not hesitate to put the brakes on if we need to. Our goal is that this should be done through as targeted local action as possible, like we did in Leicester, where we can now start to ease the restrictions. On Friday, we published our framework for containing and controlling future outbreaks in England. From Saturday, local authorities have had new powers in their areas so that they can act with more vigour in response to outbreaks. They can now close specific premises, shut outdoor public spaces, and cancel events. Later this week, we will publish indicative draft regulations that clearly set out the suite of legislative powers that Ministers may need to use to intervene at a local level.
As I pledged to the House on Thursday, we are publishing more data and sharing more data with local bodies. I bow to no one in my enthusiasm for the good use of data in decision making. Properly used, data is one of the best epidemiological weapons that we have. From last month, local directors of public health have had postcode-level data about outbreaks in their area. From today, as I committed to the House last week, we are going further and putting enhanced levels of data in the hands of local directors of public health too. Of course, high-quality testing is the main source of our data, and having set targets radically to expand testing over the past few months—which have had exactly the desired effect, as each one has been met—so we are now setting the target for the nation of half a million antigen tests a day by the end of October, ahead of winter. I am sure that, as a nation, we will meet this challenge too.
The need for extra testing is not, of course, the only challenge that winter will bring. We know that the NHS will face the usual annual winter pressures, and on top of that, we do not yet know how the virus will interact with the cold weather. So we will make sure that the NHS has the support it needs. We have massively increased the number of ventilators available to patients across the UK, up from 9,000 before the pandemic to nearly 30,000 now; we have now had an agreed supply of 30 billion pieces of personal protective equipment; and we will be rolling out the biggest ever flu vaccination programme in our country’s history.
To support this, I have agreed with the Chancellor of the Exchequer the funding necessary to protect the NHS this winter too. We have already announced £30 billion for health and social care, and we will now provide a further £3 billion on top of the £1.5 billion capital funding announced a fortnight ago. This applies to the NHS in England. Those in Scotland, Wales and Northern Ireland will also receive extra funding. This means that the NHS can keep using the extra hospital capacity in the independent sector and that we can maintain the Nightingale hospitals, which have provided so much reassurance throughout the pandemic, at least until the end of March. We have protected the NHS through this crisis, and that support will help us to protect it in the months ahead.
We all know that in the long term, the best solution to this crisis would be a vaccine, and I am delighted to say that Britain continues to lead the world on that. Two leading vaccine developments are taking place in this country, at Oxford and Imperial, and both are supported by Government funding and the British life science industry. Today, Oxford published an encouraging report in The Lancet, showing that its phase 1 and 2 trials are proceeding well. The trial shows that the Oxford vaccine produces a strong immunity response in patients, in both antibody production and T-cell responses, and that no safety concerns have been identified. That promising news takes us one step closer to finding a vaccine that could save lives around the world.
The UK is not just developing world-leading vaccines; we are also putting more money into the global work for a vaccine than any other country. With like-minded partners we are working to ensure that whoever’s vaccine is approved first, the whole world can have access. We reject narrow nationalism. We support a global effort, because this virus respects no borders, and we are all on the same side.
This morning I held a global conference call with other health leaders, including from Germany, Australia, Canada, Switzerland, the United States, and others, to discuss the need for global licensing access for any successful vaccine. Here at home, as well as our investment in research, we are working hard to build a portfolio of the most promising new vaccines, no matter where they are from. We have already secured 100 million doses of the Oxford vaccine, if it succeeds, and today I can tell the House that the Government have secured early access to 90 million further vaccine doses—30 million from an agreement between BioNTech and Pfizer, and 60 million from Valneva. We are getting the deals in place, so that once we know a vaccine is safe and effective, we can make it available for British citizens as soon as humanly possible.
Another long-term solution to eliminating this virus and its negative effects is through developing effective treatments, and it was British scientists, backed by UK Government funding, who led the first robust clinical trial to find a treatment that was proved to reduce the risk of dying from covid: dexamethasone. We now have preliminary results from a clinical trial of another treatment known as SNG001, which was created by the Southampton -based biotech firm Synairgen. Initial findings based on a small cohort suggest that SNG001 may substantially reduce the chance of someone developing severe disease, and it could cut hospital admission time by a third. The data still need to be peer reviewed, and we are supporting a further large-scale trial, but the preliminary results are a positive sign.
In the fight against this virus, our world-renowned universities, researchers and scientists are indispensable, so that we can develop the vaccines and treatments that will tackle this virus for the long term. We have a plan, our plan is working, and the measures I have set out today will help to protect the NHS, support our treatments and vaccines, and take our country forward together. I commend this statement to the House.
We in this House would all be immensely proud if a British vaccine and British drug led the world away from this deadly disease, and this is encouraging and exciting news. Will the Secretary of State ensure that there is equitable access to a vaccine when it is developed? He has my commitment that when a vaccine is available, I will stand shoulder to shoulder with him in taking on poisonous anti-vax propaganda. However, we also have to understand that there have been many false dawns in the history of infectious disease, so what happens if a vaccine does not become available? What scenario planning is the Health Secretary doing, should we be confronted with that awful prospect?
On Friday, the Prime Minister suggested that it could all be over by Christmas and that people must start returning to work by 1 August, but the chief scientific adviser said on Thursday that there was “absolutely no reason” for people to stop working from home, so will the right hon. Gentleman now publish an explanation of the scientific basis for the change in guidance with respect to home working?
On Thursday in the House, the Health Secretary insisted that we went into lockdown on 16 March, having previously told the House on 2 June that
“lockdown began on 23 March.”—[Official Report, 2 June 2020; Vol. 676, c. 704.]
The CSA revealed that SAGE advised the Government to lock down ASAP on 16 March, and Professor Ferguson has said that had lockdown been implemented sooner, we would have saved thousands of lives. The Prime Minister understandably wants to avoid a second lockdown—we all do—but if SAGE advises again on the need for a second lockdown, will it be implemented immediately, and on what criteria will he judge whether a second national lockdown is needed?
Last week, the Prime Minister also suggested that social distancing could be eased in November, predicated on a low prevalence of the virus. Can the Health Secretary define what low prevalence means, and is that the only threshold we need to meet if social distancing is to be removed by Christmas? There were no details last week about when relatives could visit care homes, even though the Secretary of State said on 9 July that an announcement was imminent. He will know that this is causing huge anxiety and upset for many families. Can he give us clarity today on when relatives can visit their loved ones in care homes?
The Prime Minister did indeed announce extra NHS funding, which is welcome, but there was no extra funding for social care. Can the Health Secretary tell us whether social care will get any more resources for this winter? We have always said—and we agree with him—that mass testing is the way in which we have to live with this virus and avoid going into a second lockdown, so we welcome the commitments to increased testing. We also know that local lockdowns may well be necessary in the future—indeed, that is the Government’s preferred response to outbreaks—but it is vital that local areas receive patient-identifiable test data on a daily basis. Why did he tell the House last week that local authorities were getting that data when in fact they were not? I think he is announcing today that they will start getting that data—he refers to “enhanced” data—but local areas could have possibly avoided lockdowns and outbreaks earlier had they had that data.
Local areas still need more clarity. In Leicester, we still do not know what metrics will be used to decide whether Leicester will be released from lockdown. Can the Health Secretary confirm, with respect to Leicester, that given the infection rate there and in neighbouring Oadby and Wigston, a decision on their future will be taken at the same time? And given that we are talking about local lockdowns—we will study the regulations carefully—will he deliver on his promise to provide support for businesses that are subject to a local lockdown, such as in Leicester?
It now appears that Blackburn is overtaking Leicester in terms of infection rates, so what does the Health Secretary make of the remarks of the director of public health in Blackburn, who said at the weekend that Test and Trace is failing and, in his words, is
“contributing to the increased risks of Covid-19”
because half of contacts are not reached? Nationally, 71% of people are being contacted, not the 80% that is needed for it to be effective. Indeed, in the Serco call centre element of Test and Trace, only 53% of cases are contacted, and a smaller proportion of contacts are identified in the most deprived areas. We still do not have an app either, despite the right hon. Gentleman’s promises, with Whitehall sources now briefing that he has a
“tendency to overpromise and only sometimes deliver”.
What a wicked, unfair thing to say about the Health Secretary! Seriously—which bit of all this is actually world beating, other than possibly the £10 billion price tag?
Today’s vaccine news is encouraging, but we still have a long way to go. We need mass testing and we welcome the Health Secretary’s commitments on that front, but will he also undertake to expand the rapid testing consortium, so that more British suppliers can be involved? Many complain about test kits and say the regulator takes ages when they give their test kits to be signed off and that emails go unanswered. We need an effective tracing regime. Rather than the ad hoc system we have at the moment, with all that money going to privatised firms, why does he not put local directors of public health in charge, backed up with primary care? We need to be preparing now for the second wave. We already have one of the highest excess death rates in the world. Lessons need to be learned. I hope the Secretary of State is learning them.
The hon. Gentleman asks what happens if there is no vaccine. If there is no vaccine—no vaccine can be guaranteed—then the next best thing is good treatment. We have the first treatment here in the UK, dexamethasone, and we have promising news of another today. We put all the support we can behind finding treatments. In fact, the UK recovery trial is the biggest—I would argue, the most effective—treatment clinical trial for covid-19 in the world. From the start, we backed our science. We supported our science, and with the help of the NHS we are able to do scientific research here with great rigour.
The hon. Gentleman mentioned the SAGE advice from March about lockdown. The SAGE advice that the CSA was referring to was implemented. That was precisely the point I was making on Thursday and I did so very straightforwardly. It was implemented straight away. If he looks at that SAGE advice and what happened, that is what he will find. I seem to remember that at the time he supported the action. Maybe now he is looking in the rear-view mirror. He should spend a bit more time looking forward, not backwards.
On social distancing, as on Leicester, the hon. Gentleman asked about the data and thresholds. We use all our data. We use all the data available to make these judgments. We do not put numerical thresholds on any particular figure. We use all data and we make judgments based on them. He also asked about data being made available to local authorities. On Thursday last week, I said I wanted to provide more data to local authorities and was going to provide more data to local authorities. We have done that today. We had provided patient-identifiable information based on postcode-level testing. We are now able to provide full information, including the name and address of those who tested positive, to local authorities where they have signed a data protection agreement.
The hon. Gentleman talked about the effectiveness of NHS Test and Trace. He needs to stop for a moment and recognise the enormous impact of NHS Test and Trace, and the 180,000 people it has been in contact with to advise them to isolate. On Blackburn, yes, it is hard sometimes in certain areas to find all the contacts, so we will be sharing with the local area the information on those whom NHS Test and Trace has not been able to contact, so that local directors of public health will be able to support the action there. Again, I think his tone on that, sniping from the sidelines, ill becomes that enormous effort and the previous work he did to support those measures across party lines.
Finally, the hon. Gentleman asks what we have learned. I would say that the thing he needs to learn—I have certainly learned it—is that things go best when we get the work of the public sector and the private sector coming together. He does not even believe his own attempt to divide us, but uses his argument just to play to his base. Honestly, there are more important things going on. We have set out a direction. We are going as hard as we can down that direction of travel, and we have announced to the House further action in that direction of travel. He should get alongside.
The central challenge we now face is that according to the latest figures and as the Secretary of State knows, about 1,700 people a day are being infected by the virus and about 400 a day are going into NHS Test and Trace, which is about a quarter. As we think about how to prevent a second wave, will he give the House some details as to how we are going to bridge that gap so that we can go into our Christmas holiday with the same cautious optimism as we are going into our summer one?
In the covid statement last Thursday, I again raised the issue of delays in providing individual test results to local public health teams. The Health Secretary said he could not answer so many questions from me, so he chose not to answer any. To make it simple, I will ask only one. Postcode information was utterly insufficient, so by what date can he guarantee that every single director of public health in England will receive the identifiable details of all new positive cases on a daily basis?
I say to all those in the shielding category that we have recommended that shielding restrictions come to an end at the end of this month because it is clinically advised that the levels of new infections are low enough that it is safe to do so. It is safe to do so. I plead with those who are shielding to listen to this clinical advice, because we also know that staying at home and not seeing other people has downsides to health too. If anyone wants proof that we will not take this step unless we are confident that it is safe, we have paused the end of shielding in Leicester exactly because rates of infection are higher—to keep people safe. People can be assured that it is safe, from the end of this month, for those in the shielding category to go out into the community, taking the precautions that everybody should take.
I also take this opportunity to answer part of the question from my hon. Friend the Member for South Derbyshire (Mrs Wheeler) that I did not answer. More powers, as well more data, will be available to local areas to take more local action themselves, without having to refer up to the Secretary of State to use my powers. Of course, national Government hold further powers for significant action, which we have had to use just the once, but we will give local areas more powers, as well as more data, to be able to grip this issue locally.
There is a news story today that there is a rise in infections in France, so this dreadful virus is still there. Does the Secretary of State agree that more firm leadership on the importance of wearing masks is very important, and will he take my assurance that the anti-vaxxers have to be confronted? I have just seen statistics that a quite high percentage of NHS employees are very resistant to getting the flu jab in the winter. That is a great challenge. Together, does he agree that we can face it down?
We have been working really hard with Huddersfield and the local authorities in the hon. Gentleman’s part of the world to bring the virus under control. It has been a real team effort and an example of how things should be done working together. I appreciate the hon. Gentleman’s words on that. I hope that the whole local team will see that this is a big cross-party effort and that there is not some sort of fake attempt to create division. This is everybody working together to try to tackle this virus, and that is how it should be.
On the latter point, I agree with the hon. Gentleman very strongly about tackling the anti-vax movement, and he is right to raise that. He is also right that this is not just about the covid vaccine, but the flu vaccine too. We are moving to make sure that a far higher proportion of people in the NHS get the flu vaccine. This winter, the expectation will be that every single person who works in the NHS will get the flu vaccine, unless there is a very good, essentially clinical, reason. Making that happen is a big part of the work I am doing with Simon Stevens and the NHS leadership, to drive that through.
Secondly, we will also have a communications campaign. To answer a point that was raised earlier but to which I did not respond at the time, we have already published a plan for the order in which people will have access to the vaccine, starting with the most vulnerable. In essence, it consists of going down by age through those with comorbidities and health and social careworkers. We have to make sure that we reassure people and that we assure them that we are doing the roll-out in a clinically valid way.
Finally, on Southampton, my right hon. Friend is an assiduous representative of the environs of Southampton. When Southampton is doing well, Romsey is undoubtedly part of Southampton. In this case, Southampton is doing very well; let us hope that it continues.
On the second point, my hon. Friend is absolutely right. We have been working hand in glove with these brilliant scientists, and we should put it on the record, even though it might take me an extra 30 seconds to say it, Mr Deputy Speaker, that the Medicines and Healthcare Products Regulatory Agency has done an amazing job. Alongside the scientists, it has made sure the trials are designed so that it can approve the results as soon as the results come forward—essentially, in parallel, rather than afterward, which is the norm. The MHRA has played a blinder; it is one of the reasons that the UK is at the forefront in vaccines and treatments. That means the vaccine will be available as soon as humanly possible as soon as the science is proven.
“will be rolled out over the coming three to four weeks”.—[Official Report, 29 June 2020; Vol. 678, c. 117.]
Can he confirm whether that is now complete, or will be by the end of the week?
If, in addition, the hon. Lady seeks a threshold—a figure—at which point a local lockdown is triggered, we are not going to do that. The reason we are not going to do that is that we have to take everything into account, including local circumstances. For instance, last week the number of cases in Herefordshire shot up—on some counts, it became one of the places with the most cases in the country—but we know that that was confined on one farm, so it was far better to tackle that one farm than to shut down the whole of Herefordshire. That is a clear example of why this simplistic call for a single threshold is not the right approach. The right approach is a scientific approach, using all the available data and people’s judgment.
Virtual participation in proceedings concluded (Order, 4 June).
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.